Page last updated: 2024-08-24

imiquimod and Lung Neoplasms

imiquimod has been researched along with Lung Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arimura, A; Kanekura, T; Kirishima, M; Tanimoto, A	1
Benninghoff, B; Jablonska, S; Majewski, S; Marczak, M; Mlynarczyk, B	1
Bogeschdorfer, F; Gronau, S; Riechelmann, H	1
Chen, WR; Naylor, MF; Nordquist, RE; Perry, LA; Teague, TK	1

Reviews

1 review(s) available for imiquimod and Lung Neoplasms

Article	Year
[New substances in the therapy of head and neck cancer]. Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7 Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration	2006

Article

Year

[New substances in the therapy of head and neck cancer].

Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7

Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration

2006

Other Studies

3 other study(ies) available for imiquimod and Lung Neoplasms

Article	Year
Eruptive squamous cell carcinoma in a patient treated with concomitant pembrolizumab and imiquimod. The Journal of dermatology, 2019, Volume: 46, Issue:12 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Lung Neoplasms; Neoplasms, Second Primary; Skin Neoplasms; Urinary Bladder Neoplasms	2019
Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis. International journal of dermatology, 2005, Volume: 44, Issue:1 Topics: Adjuvants, Immunologic; Aminoquinolines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bowen's Disease; Cell Line, Tumor; Disease Models, Animal; Humans; Imiquimod; Interferon-alpha; Interleukin-18; Keratinocytes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Papillomaviridae; Papillomavirus Infections; Sarcoma; Skin Neoplasms; Tumor Necrosis Factor-alpha	2005
In situ photoimmunotherapy: a tumour-directed treatment for melanoma. The British journal of dermatology, 2006, Volume: 155, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Imiquimod; Infrared Rays; Laser Therapy; Lung Neoplasms; Male; Melanoma; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Toll-Like Receptors; Treatment Outcome	2006